|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0010583,
umls-concept:C0013216,
umls-concept:C0014582,
umls-concept:C0016360,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205225,
umls-concept:C0750729,
umls-concept:C1280500,
umls-concept:C1521761,
umls-concept:C1521808,
umls-concept:C1948023,
umls-concept:C2603343
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-1-4
|
|
pubmed:abstractText |
The neutropenia induced by six courses of an intensified FEC regimen is expected to be checked by early primary administration of G-CSF which is stopped eight days before the next chemotherapy course. Less information is available about megakaryocytic and erythroid toxicity over six courses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
pubmed-author:AscariEE,
pubmed-author:BovioAA,
pubmed-author:BrugnatelliSS,
pubmed-author:DanovaMM,
pubmed-author:De MonteAA,
pubmed-author:FavaSS,
pubmed-author:FregoniVV,
pubmed-author:GiordanoMM,
pubmed-author:KlersyCC,
pubmed-author:NastasiGG,
pubmed-author:PugliesePP,
pubmed-author:RiccardiAA,
pubmed-author:RichettiAA,
pubmed-author:RinaldiEE,
pubmed-author:TinelliCC,
pubmed-author:TrottaOO
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
84
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
540-6
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:9862513-Adult,
pubmed-meshheading:9862513-Aged,
pubmed-meshheading:9862513-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9862513-Bone Marrow,
pubmed-meshheading:9862513-Breast Neoplasms,
pubmed-meshheading:9862513-Cyclophosphamide,
pubmed-meshheading:9862513-Drug Administration Schedule,
pubmed-meshheading:9862513-Epirubicin,
pubmed-meshheading:9862513-Female,
pubmed-meshheading:9862513-Fluorouracil,
pubmed-meshheading:9862513-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9862513-Humans,
pubmed-meshheading:9862513-Middle Aged,
pubmed-meshheading:9862513-Prospective Studies,
pubmed-meshheading:9862513-Time Factors,
pubmed-meshheading:9862513-Treatment Outcome
|
|
pubmed:articleTitle |
Myeloprotective effect of early primary granulocyte-colony stimulating factor during six courses of intensified 5-fluorouracil, epirubicin and cyclophosphamide (120FEC) chemotherapy for advanced breast cancer. Cooperative Group of Study and Treatment of Breast Cancer.
|
|
pubmed:affiliation |
Medicina Interna e Oncologia Medica, Università and IRCCS Policlinico San Matteo, Pavia, Italy. riccardi@mbox.medit.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
